Oren Livnat
Stock Analyst at HC Wainwright & Co.
(0)
# 3399
Out of 5,218 analysts
194
Total ratings
41.12%
Success rate
2.07%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Trevi Therapeutics | Reiterates: Strong Buy | 6 8 | 4.17 | 79.86% | 5 | Dec 13, 2024 | |
Pacira BioSciences | Reiterates: Buy | 39 39 | 19.82 | 96.77% | 18 | Dec 4, 2024 | |
Jazz Pharmaceuticals | Reiterates: Buy | 200 200 | 123 | 62.6% | 16 | Nov 22, 2024 | |
Zevra Therapeutics | Reiterates: Buy | 20 20 | 8.47 | 136.13% | 8 | Nov 20, 2024 | |
Avadel Pharmaceutica... | Maintains: Buy | 27 25 | 10.4 | 140.38% | 14 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 7 | 3.27 | 101.83% | 10 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 94 94 | 56.38 | 66.73% | 11 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 11 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | n/a | n/a | 2 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 47 50 | 30.07 | 66.28% | 8 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 13 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 57 61 | 52.62 | 15.93% | 8 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 6.54 | 14.68% | 6 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 | n/a | n/a | 9 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 6 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 10 | n/a | n/a | 4 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 24 17 | n/a | n/a | 6 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Aug 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 8 | 1.14 | 601.75% | 2 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 6 | n/a | n/a | 4 | Apr 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 5 | n/a | n/a | 5 | Jan 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 60 | 5.09 | 1068.96% | 5 | Aug 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 8 | n/a | n/a | 2 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 252 198 | 2.55 | 7664.71% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | n/a | n/a | 6 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 13 | n/a | n/a | 2 | Oct 15, 2018 |